Loading
Latest filing published 25 Sept 2023 for Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.), €35k.
All filings by Adele Madelyn Gulfo on record concern Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). Over a trading history stretching from 25 June 2019 to 22 September 2023, the count stands at 11 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 25 September 2023, the filings show an option exercise worth €35k in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 4 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations